Loading…
Assembly Biosciences, Inc. is projected to rise to $26.36 by 2027, a +5% move from its current price of $25.11. ASMB is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $24.43 | $25.12 | $25.83 | +0.05% |
| Aug 4 | $24.16 | $25.13 | $26.15 | +0.10% |
| Aug 5 | $23.96 | $25.15 | $26.40 | +0.15% |
| Aug 6 | $23.79 | $25.16 | $26.61 | +0.20% |
| Aug 7 | $23.65 | $25.17 | $26.80 | +0.25% |
| Aug 8 | $23.52 | $25.18 | $26.97 | +0.30% |
| Aug 9 | $23.40 | $25.20 | $27.13 | +0.34% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $23.40 | $25.20 | $27.13 | +0.34% |
| Week 2 | $22.77 | $25.28 | $28.07 | +0.69% |
| Week 3 | $22.32 | $25.37 | $28.84 | +1.04% |
| Week 4 | $21.96 | $25.46 | $29.52 | +1.39% |
| Week 5 | $21.65 | $25.55 | $30.14 | +1.74% |
| Week 6 | $21.38 | $25.63 | $30.73 | +2.09% |
| Week 7 | $21.15 | $25.72 | $31.28 | +2.44% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Assembly Biosciences, Inc. is a biotechnology company that develops therapeutic candidates for the treatment of viral diseases worldwide. It was incorporated in 2005 and is headquartered in South San Francisco, California. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014.
Assembly Biosciences, Inc. (ASMB) is a biotechnology stock currently priced at $26.73 per share. It has a market capitalization of $529.72M and is ranked 3018 by market cap.
A major floor 14.8% below — a decisive break under it would weaken the trend.
The nearest floor, 3.4% below — buyers have tended to step in here.
The nearest ceiling, 15.4% above — a clean break opens room to run.
A major ceiling 26.3% above — clearing it would confirm fresh momentum.
Key ASMB support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ASMB market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $25.55 | Sell | $25.51 | Sell |
| MA 10 | $25.61 | Sell | $25.73 | Sell |
| MA 20 | $26.55 | Sell | $26.00 | Sell |
| MA 50 | $25.85 | Sell | $26.37 | Sell |
| MA 100 | $27.26 | Sell | $26.98 | Sell |
| MA 200 | $29.24 | Sell | $26.68 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.78 | Neutral |
| Stoch RSI (14) | 25.34 | Neutral |
| CCI (20) | -94.83 | Neutral |
| Williams %R (14) | -97.14 | Info |
| MACD (12,26,9) | -0.15 | Sell |
| ROC (12) | -6.06 | Sell |
| Bollinger %B (20,2) | 0.21 | Neutral |
| Stochastic %K (14) | 2.86 | Buy |
| TRIX (15) | -0.03 | Sell |
| Awesome (5,34) | -0.53 | Sell |
| Ultimate (7,14,28) | 41.00 | Neutral |
| Momentum (10) | -1.70 | Sell |
| Aroon Osc (25) | 28.00 | Buy |
| Hull MA (9) | 25.44 | Sell |
| ADX (14) | 10.05 | Neutral |
| ATR (14) | 0.71 | Info |
The sentiment is BULLISH with RSI(14) at 50. The stock trades around the 50-day simple moving average of $26.78 and the 200-day simple moving average of $29.20.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $22.26 | $25.11 | $32.00 | 0% | Neutral | |
| $20.98 | $26.36 | $35.05 | +5% | Neutral | |
| $23.05 | $29.81 | $41.19 | +19% | Neutral | |
| $25.02 | $33.15 | $47.19 | +32% | Bullish | |
| $28.49 | $38.55 | $56.27 | +54% | Bullish | |
| $34.45 | $47.53 | $70.90 | +89% | Bullish | |
| $35.65 | $50.07 | $76.17 | +99% | Bullish | |
| $36.90 | $52.70 | $81.60 | +110% | Bullish | |
| $38.94 | $56.51 | $88.92 | +125% | Bullish | |
| $36.67 | $54.03 | $86.30 | +115% | Bullish | |
| $59.04 | $93.24 | $158.62 | +271% | Bullish | |
| $103.96 | $185.02 | $344.91 | +637% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $22.26 | $25.11 | $30.19 | +0.00% |
| September 2026 | $21.39 | $25.33 | $30.85 | +0.87% |
| October 2026 | $22.03 | $26.26 | $32.34 | +3.68% |
| November 2026 | $21.95 | $26.32 | $32.70 | +0.24% |
| December 2026 | $21.20 | $25.55 | $32.00 | -2.92% |
Click any year to see its month-by-month ASMB forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect ASMB to range from $22.26 to $32.00 through 2026. The $25.11 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The ASMB price prediction for 2027 points to an average of $26.36 (low $20.98, high $35.05) — a potential gain of +5% on today's $25.11. A consolidation phase looks the most probable path here.
In 2028, ASMB is projected to trade between $23.05 and $41.19, averaging $29.81 — a potential gain of +19% from today's $25.11. That is up +13% on the projected 2027 average. Price action looks broadly range-bound.
Assembly Biosciences, Inc.'s 2029 outlook centres on $33.15, within a $25.02 to $47.19 range. That is up +11% on the projected 2028 average. That marks a +32% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, ASMB could reach as high as $56.27, with a base case around $38.55 and support toward $28.49 — roughly +54% from $25.11. Momentum favours further upside here.
Expect ASMB to range from $34.45 to $70.90 through 2031. The $47.53 average target implies a +89% move from current prices. That is up +23% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The ASMB price prediction for 2032 points to an average of $50.07 (low $35.65, high $76.17) — a potential gain of +99% on today's $25.11. Momentum favours further upside here.
In 2033, ASMB is projected to trade between $36.90 and $81.60, averaging $52.70 — a potential gain of +110% from today's $25.11. That is up +5% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Assembly Biosciences, Inc.'s 2034 outlook centres on $56.51, within a $38.94 to $88.92 range. That is up +7% on the projected 2033 average. That marks a +125% change versus current levels. Momentum favours further upside here.
By 2035, ASMB could reach as high as $86.30, with a base case around $54.03 and support toward $36.67 — roughly +115% from $25.11. Buyers look set to stay in control over this stretch.
Expect ASMB to range from $59.04 to $158.62 through 2040. The $93.24 average target implies a +271% move from current prices. That is up +73% on the projected 2035 average. Momentum favours further upside here.
The ASMB price prediction for 2050 points to an average of $185.02 (low $103.96, high $344.91) — a potential gain of +637% on today's $25.11. Buyers look set to stay in control over this stretch.
Investing $1,000 in ASMB today (≈ 39.824771 ASMB) could be worth
$7,368.25
+$6,368.25 (+637%) by 2050 · US Dollar
Based on the average projected ASMB price of $185.02 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ASMBwould be worth at today's price.
$1,000 invested in ASMB on Jul 31, 2025 (≈ 55.772447 ASMB) would be worth
$1,400.45
+$400.45 (+40.0%) today · 1.40× · US Dollar
Based on a ASMB entry price of $17.93 vs. today's $25.11.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $25.55 | $982.78 | -1.7% |
| 1 month ago | $26.69 | $940.8 | -5.9% |
| 3 months ago | $27.37 | $917.43 | -8.3% |
| 6 months ago | $26.37 | $952.22 | -4.8% |
| 1 year ago | $17.93 | $1,400.45 | +40.0% |
| All time (5.0y) ago | $43.92 | $571.72 | -42.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ASMB forecast.
Our base-case forecast reaches $50.00 around 2032.
Implied market cap at $50.00: $990.86M
The multi-year forecast shows ongoing upside, with the 2026 avg price of $26.73 (min $22.26, max $34.37; ROI 0%), 2027 avg $29.58 (max $39.35; ROI 10.7%), 2028 avg $32.89 (max $45.41; ROI 23%). The 2030 forecast lists an avg of $45.56 (max $66.40; ROI 70.4%), 2040 avg $114.73 (max $194.52; ROI 329.2%), and 2050 avg $239.56 (max $444.74; ROI 796.2%). These figures imply bullish longer-term potential with increasing upside alongside higher max targets; however, these are estimates and not guarantees.
Tap a question to reveal the answer.
In 2030, the avg forecast price is $45.56, with a max of $66.40 and an ROI of 70.4%, and the sentiment is BULLISH.
The forecast shows rising average prices across years with positive ROIs such as 70.4% in 2030, 329.2% in 2040, and 796.2% in 2050, but these are estimates and not guaranteed.
Yes—the forecast max by 2040 is $194.52 and by 2050 is $444.74, so surpassing $100 is within the projected range.
Current price is $26.73 and market cap is $529.72M.
The 30-day range is $22.28 to $32.07, and annualized volatility is 50%.
Assembly Biosciences, Inc. Community Discussion
0Share your Assembly Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.